NASDAQ

Scribe Therapeutics Inc. (SCTX)

♥ 761 Thanks from members

Live price chart, market sentiment, and community perspectives for Scribe Therapeutics Inc. (NASDAQ: SCTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Jennifer DoudnaFounder: Benjamin OakesLeadership: Benjamin Oakes (CEO)Holder: Venture Capital InvestorsEngineered CRISPR EnzymesIn Vivo Gene Editing Therapies#SCTX#Scribe Therapeutics#CRISPR#Gene Editing#Biotech